Search fresh public links, source activity, and ready-to-use post angles for Glp‑1 Medications.
Fresh curated links around GLP‑1 medications are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kai...
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, researchers report.
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...
What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly e...
The different medications work to help regulate appetite and blood sugar levels.
While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly.
THURSDAY, July 9, 2026 — The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That’s about 40 million people — as many folks who live in Calif...
NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and lo...
The use of GLP-1 medications for weight loss has skyrocketed, but there are side effects.
GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?
MONDAY, June 15, 2026 — Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure. A new Northwestern Medicine study tracked more than 42,000...
GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabe...
THURSDAY, June 25, 2026 — As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study. A team led by Jordan Miller...
GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?
In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged primarily as breakthrough medications targeting metabolic disorders such as type 2 diabetes and obes...
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fig...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.